News

Medigene and Cytovant enter into service agreement for DC vaccine manufacturing process development

SHOW RELEASE

Three Medigene poster presentations at SITC Annual Meeting

SHOW RELEASE

Medigene expands patent protection of its technologies

SHOW RELEASE

Medigene participates at upcoming virtual conferences

SHOW RELEASE

Strategic measures including restructuring with extension of cash runway and improved EBITDA

SHOW RELEASE

Medigene provides Q2 update and 6M report 2020

SHOW RELEASE

Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers

SHOW RELEASE

Medigene's PD1-41BB switch receptor enhances TCR-T cell activity towards solid tumors

SHOW RELEASE

Medigene participates at upcoming virtual conferences

SHOW RELEASE

Medigene provides Q1 2020 update

SHOW RELEASE

Medigene was granted two patents for novel CrossTAg-1 technology

SHOW RELEASE

Medigene provides results for fiscal year 2019 and outlook

SHOW RELEASE

Phio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with Medigene

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Medigene, IRICoR and Université de Montréal sign collaboration and exclusive licensing option on novel cancer antigens

SHOW RELEASE